Renovaro BioSciences Targets Pancreatic Cancer Through Work With GEDI Cube AI Platform, NVIDIA Resources
LOS ANGELES, CA - (NewMediaWire) - September 21, 2023 - (InvestorBrandNetwork via NewMediaWire) - IBN, a multifaceted financial news, content creation and publishing company, is utilized by both public and private companies to optimize investor awareness and recognition.
California-based cancer fighter Renovaro BioSciences is turning the power of its immune system-promoting technology to the fight against pancreatic cancer and other illnesses that tend to leave patients with a short life expectancy once they are diagnosed
Renovaro recently announced a binding, exclusive letter of intent ("LOI") to add GEDI Cube's artificial intelligence ("AI") data mining technology to its fight against such cancers
GEDI Cube is strengthening its platform's potential by joining with the NVIDIA Inception program, which nurtures start-ups by providing access to cutting-edge technology, technical resources, and venture capitalists
The companies hope to detect pancreatic tumors at early stages when they can be more effectively treated, using predictive modeling to analyze patients' health profiles and potential responsiveness to therapeutic efforts
Pre-clinical biotechnology innovator Renovaro BioSciences (NASDAQ: RENB) is seeking solutions for hard-to-treat cancers and other illnesses through the use of a proprietary cell and gene solution designed to promote immune system response.
The company has demonstrated the potential of its novel technology against solid tumors in humanized mouse models that demonstrated significant pancreatic tumor size and weight reduction. Renovaro has applied for Investigational New Drug ("IND") status that would facilitate shipping the company's
NOTE TO INVESTORS: The latest news and updates relating to RENB are available in the company's newsroom at https://ibn.fm/RENB
About IBN
IBN has introduced 50+ distinct investor-focused brands over the last 15+ years and has leveraged these unique brands to amass a collective audience of millions of social media followers. In conjunction with 5,000+ syndication partnerships, IBN's broad-based investor-facing brands help fulfill the diverse demands and needs of our rapidly growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, harnessing the energy and experience of our team of specialized experts to exceed the expectations of each of our client-partners.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
Corporate Communications
IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com